Nova Susan Tina's most recent trade in Veracyte Inc was a trade of 103,043 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 3, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Veracyte Inc | Nova Susan Tina | President, CLIA U.S. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 103,043 | 103,043 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Nova Susan Tina | President, CLIA U.S. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 56,546 | 76,988 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Nova Susan Tina | President, CLIA U.S. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.84 per share. | 02 Mar 2022 | 10,695 | 20,442 (0%) | 0% | 27.8 | 297,749 | Common Stock |